BioStock: Phase II results indicate durability of response for Alligator's CD40 agonist - allaaktier.se

Nyheter Alligator Bioscience Nyheter alla bolag

Slipp dessa annonser och få en massa andra godsaker med vårt premiumabonnemang.

BioStock: Phase II results indicate durability of response for Alligator's CD40 agonist

Read the interview with Sumeet Ambarkhane at biostock.se:

https://www.biostock.se/en/2023/06/phase-ii-results-indicate-durability-of-response-for-alligators-cd40-agonist/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

Datum	2023-06-30, kl 11:46
Källa	Cision